Pharmacokinetics and safety of a novel recombinant soluble human thrombomodulin, ART-123, in healthy male volunteers

Journal of Clinical Pharmacology

Volumn 38, Issue 1, 1998, Pages 40-44

  Nakashima, Mitsuyoshi ^a   Kanamaru, Mitsutaka ^a   Umemura, Kazuo ^a   Tsuruta, Kazuhisa ^b  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ASAHI CHEMICAL INDUSTRY CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN; RECOMBINANT THROMBOMODULIN; THROMBOMODULIN; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; JAPAN; MALE; NORMAL HUMAN; PHARMACOKINETICS;

EID: 0031951276     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1998.tb04375.x     Document Type: Article

References (19)

1. Esmon CT, Esmon NL, Harris KW: Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. J Biol Chem 1982;257:7944-7947.
2. Esmon NL, Owen WG, Esmon CT: Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 1982;257:859-864.
3. Esmon NL, Carroll RC, Esmon CT: Thrombomodulin blocks the ability of thrombin to activate platelets. J Biol Chem 1983;258:12238-12242.
4. Vehar GA, Davie EW: Preparation and properties of bovine factor VIII (antihemophilic factor). Biochemistry 1980;19:401-410.
5. Suzuki K, Stenflo J, Dahlback B, Teodorsson B: Inactivation of human coagulation factor V by activated protein C. J Biol Chem 1983;258:1914-1920.
6. Salem HH, Maruyama I, Ishii H, Majerus PW: Isolation and characterization of thrombomodulin from human placenta. J Biol Chem 1984;259:12246-12251.
7. Suzuki K, Kusumoto H, Deyashiki Y, Nishioka J, Maruyama I, Zushi M, et al: Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C. EMBO J 1987;6:1891-1897.
8. Zushi M, Gomi K, Yamamoto S, Maruyama I, Hayashi T, Suzuki K: The last three consecutive epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity. J Biol Chem 1989;264:10351-10353.
9. Zushi M, Gomi K, Honda G, Kondo S, Yamamoto S, Hayashi T, Suzuki K: Aspartic acid 349 in the fourth epidermal growth factor-like structure of human thrombomodulin plays a role in its Ca2+-mediated binding to Protein C. J Biol Chem 1991;266:19886-19889.
10. Gomi K, Zushi M, Honda G, Kawahara S, Matsuzaki O, Kanabayashi T, et al: Antithrombotic effect of recombinant human thrombomodulin on thrombin-induced thromboembolism in mice. Blood 1990;75:1396-1399.
11. Aritomi M, Watanabe N, Ohishi R, Gomi K, Kiyota T, Yamamoto S, et al: Recombinant human soluble thrombomodulin delivers bounded thrombin to antithrombin III: thrombomodulin associates with free thrombin and is recycled to activate protein C. Thromb Haemostos 1993;70:418-422.
12. Ohishi R, Watanabe N, Aritomi M, Gomi K, Kiyota T, Yamamoto S, et al: Evidence that the protein C activation pathway amplifies the inhibition of thrombin generation by recombinant human thrombomodulin in plasma. Thromb Haemostas 1993;70:423-426.
13. Gonda Y, Hirata S, Saitoh K, Aoki Y, Mohri M, Gomi K, et al: Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats. Thromb Res 1993;71:325-335.
14. Mohri M, Oka M, Aoki Y, Gonda Y, Hirata S, Gomi K, et al: Intravenous extended infusion of recombinant human soluble thrombomodulin prevented tissue factor-induced disseminated intravascular coagulation in rats. Am J Hematol 1994;45:298-303.
15. Aoki Y, Takei R, Mohri M, Gonda Y, Gomi K, Sugihara T, et al: Antithrombotic effects of recombinant human soluble thrombomodulin (rhs-TM) on arteriovenous shunt thrombosis in rats. Am J Hematol 1994;47:162-166.
16. Aoki Y, Ohishi R, Takei R, Matsuzaki O, Mohri M, Saitoh K, et al: Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III. Thromb Haemostas 1994;71:452-455.
17. Honda G, Masaki C, Zushi M, Tsuruta K, Sata M, Mohri M, et al: The roles played by the D2 and D3 domains of recombinant human thrombomodulin in its function. J Biochem 1995;118:1030-1036.
18. Akaike H: a new look at the statistical model identification. IEEE Trans Automat Contr 1973;19:716-723.
19. Yamaoka K, Tanigawara Y, Nakagawa T, Uno T: A pharmacokinetic analysis program for microcomputer. J Pharmacobiodyn 1981;4:879-885.